Effects of arthroscopic anterior cruciate ligament reconstruction combined with sodium hyaluronate on inflammatory factors in anterior cruciate ligament injury patients with or without knee osteoarthritis
Advances in Clinical and Experimental Medicine · 2022
DOI: 10.17219/acem/156659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2022. Verfasst von Yongjun Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Second Xiangya Hospital and Central South University, Changsha, China. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament Injuries, Osteoarthritis, Knee, Anterior Cruciate Ligament Reconstruction. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: Anterior cruciate ligament injury (ACLI) is a common sports injury of the knee joint, and ACLI patients often develop early knee osteoarthritis (KOA) after surgery. This may be due to the activation of a post-surgical inflammatory response. OBJECTIVES: To investigate the treatment efficacy of arthroscopic anterior cruciate ligament reconstruction (AACLR) combined with sodium hyaluronate (SH) in ACLI patients with and without KOA. MATERIAL AND METHODS: This prospective cohort study included 226 ACLI patients with or without KOA who were admitted between July 2015 and December 2018 into The Second Xiangya Hospital, Changsha, China. All patients received AACLR surgery combined with 50 mg SH. Serum levels of inflammatory markers were evaluated with enzyme-linked immunosorbent assay (ELISA), and knees were assessed using the Lysholm Knee Score and the International Knee Documentation Committee Knee Evaluation Form (IKDC). The range of motion of the knee joint was also measured. RESULTS: The mean disease course was 73.39 ±30.90 months for ACLI patients with KOA, which was significantly longer than for those without KOA (3.74 ±1.70 months). Also, surgery duration was remarkably longer for patients with KOA than it was for those without this disease. The Lysholm Knee Score and IKDC score, as well as the range of knee joint motion were significantly improved in all patients after treatment compared to baseline. However, no significant differences were found between the groups. One day, 3 days and 7 days after surgery, significantly higher inflammatory marker levels were found in the patients with KOA than in those without KOA. CONCLUSIONS: The AACLR combined with SH was efficacious as it improved knee function and inflammation in all patients, while patients without KOA exhibited a more rapid recovery from the post-surgical inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Second Xiangya Hospital and Central South University, Changsha, China.
- Department of General Surgery, The Second Xiangya Hospital and Central South University, Changsha, China.
Zitieren
APA
Hu, Y., Shen, Y., Chen, D., & Zhong, W. (2022). Effects of arthroscopic anterior cruciate ligament reconstruction combined with sodium hyaluronate on inflammatory factors in anterior cruciate ligament injury patients with or without knee osteoarthritis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/156659
Vancouver
Hu Y, Shen Y, Chen D, Zhong W. Effects of arthroscopic anterior cruciate ligament reconstruction combined with sodium hyaluronate on inflammatory factors in anterior cruciate ligament injury patients with or without knee osteoarthritis. Advances in Clinical and Experimental Medicine. 2022. doi:10.17219/acem/156659
BibTeX
@article{Hu2022,
author = {Hu, Yongjun and Shen, Yi and Chen, Ding and Zhong, Weiye},
title = {Effects of arthroscopic anterior cruciate ligament reconstruction combined with sodium hyaluronate on inflammatory factors in anterior cruciate ligament injury patients with or without knee osteoarthritis},
journal = {Advances in Clinical and Experimental Medicine},
year = {2022},
doi = {10.17219/acem/156659}
}
EUVIMED